Vaccine supply outstrips demand, access inequity remains

More than 13 billion doses have been produced since the pandemic, 11 billion of which have been administered, according to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).

PREMIUM World

Vaccine supply outstrips demand, access inequity remains
By NewVision Reporter
Journalists @NewVision
#Covid-19 #Vaccine

After two years of racing to vaccinate the world against Covid-19, the number of available doses now surpasses demand in many areas.

Yet a yaiwning gap remains in vaccination rates between

Login to begin your journey to our premium content